Nge Sze Amanda Mak

Title: Nge Sze Amanda Mak: Innovator in Bispecific Tetravalent Antibodies

Introduction

Nge Sze Amanda Mak is a prominent inventor based in Bellevue, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of bispecific tetravalent antibodies. His innovative work has the potential to advance therapeutic options in various medical applications.

Latest Patents

Nge Sze Amanda Mak holds a patent for "Bispecific tetravalent antibodies and methods of making and using thereof." This patent describes a bispecific tetravalent antibody that comprises an IgG with a pair of heavy chains and a pair of light chains, along with two scFv components connected to either the C or N terminals of the heavy or light chains. The antibody is designed to have binding specificity for two different members of the EGFR family, showcasing its potential in targeted therapies.

Career Highlights

Currently, Nge Sze Amanda Mak is associated with Systimmune, Inc., where he continues to push the boundaries of antibody technology. His work is instrumental in developing novel therapeutic strategies that could lead to improved patient outcomes.

Collaborations

Throughout his career, Nge Sze Amanda Mak has collaborated with notable colleagues, including Zeren Gao and Phil Tan. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Nge Sze Amanda Mak is a key figure in the development of bispecific tetravalent antibodies, with a focus on advancing medical therapies. His contributions to biotechnology are paving the way for future innovations in the industry.